Description |
Product Type |
Product Size |
Tablet |
20'S |
Product Company |
Ferozesons laboratories |
Acyclovir 400mg
|
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Macter Pharma
|
Zoledronic Acid 4mg/5ml
|
Product Type |
Product Size |
Product Company |
Injection |
1'S |
Aqvida |
|
Product Type |
Product Size |
Product Company |
Injection |
1'S |
Himmel Pharma |
|
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Himmel Pharma
|
Topotecan 4mg/4ml
|
Product Type |
Product Size |
Tablet |
30'S |
Product Company |
Pfizer |
Amlodipine besylate 5mg
|
Content | Acyclovir is in a class of antiviral medications called synthetic nucleoside analogues. It works by stopping the spread of the herpes virus in the body. Acyclovir will not cure genital herpes and may not stop the spread of genital herpes to other people.
| Zoledronic acid is used to treat high levels of calcium in the blood that may be caused by certain types of cancer.
| Oxaliplatin is a platinum-based chemotherapy drug in the same family as cisplatin and carboplatin. It is typically administered in combination with fluorouracil and leucovorin in a combination known as Folfox for the treatment of colorectal cancer. Compared to cisplatin the two amine groups are replaced by cyclohexyldiamine for improved antitumour activity. The chlorine ligands are replaced by the oxalato bidentate derived from oxalic acid in order to improve water solubility. | Gemcitabine is a cytidine analog with two fluorine atoms.As a prodrug, gemcitabine is transformed into its active metabolites that work by replacing the building blocks of nucleic acids during DNA elongation, arresting tumour growth and promoting apoptosis of malignant cells. | Topotecan is an antineoplastic agent used to treat ovarian cancer, small cell lung cancer, or cervical cancer.
| Amlodipine is an oral antihypertensive medicine that belongs to the class of calcium channel blockers. It works by relaxing the blood vessels to allow easy flow of blood
|
Reviews
There are no reviews yet.